1. Home
  2. NEPH vs HHS Comparison

NEPH vs HHS Comparison

Compare NEPH & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • HHS
  • Stock Information
  • Founded
  • NEPH 1997
  • HHS 1923
  • Country
  • NEPH United States
  • HHS United States
  • Employees
  • NEPH N/A
  • HHS N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • HHS Advertising
  • Sector
  • NEPH Health Care
  • HHS Consumer Discretionary
  • Exchange
  • NEPH Nasdaq
  • HHS Nasdaq
  • Market Cap
  • NEPH 36.1M
  • HHS 30.3M
  • IPO Year
  • NEPH 2004
  • HHS N/A
  • Fundamental
  • Price
  • NEPH $3.65
  • HHS $4.03
  • Analyst Decision
  • NEPH Buy
  • HHS
  • Analyst Count
  • NEPH 1
  • HHS 0
  • Target Price
  • NEPH $5.00
  • HHS N/A
  • AVG Volume (30 Days)
  • NEPH 65.9K
  • HHS 31.2K
  • Earning Date
  • NEPH 08-07-2025
  • HHS 08-07-2025
  • Dividend Yield
  • NEPH N/A
  • HHS N/A
  • EPS Growth
  • NEPH N/A
  • HHS N/A
  • EPS
  • NEPH 0.08
  • HHS N/A
  • Revenue
  • NEPH $15,517,000.00
  • HHS $181,355,000.00
  • Revenue This Year
  • NEPH $17.06
  • HHS $6.54
  • Revenue Next Year
  • NEPH $12.20
  • HHS N/A
  • P/E Ratio
  • NEPH $47.45
  • HHS N/A
  • Revenue Growth
  • NEPH 10.34
  • HHS N/A
  • 52 Week Low
  • NEPH $1.36
  • HHS $3.24
  • 52 Week High
  • NEPH $5.00
  • HHS $8.80
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 50.89
  • HHS 40.53
  • Support Level
  • NEPH $3.83
  • HHS $3.61
  • Resistance Level
  • NEPH $4.25
  • HHS $4.05
  • Average True Range (ATR)
  • NEPH 0.40
  • HHS 0.57
  • MACD
  • NEPH -0.10
  • HHS 0.01
  • Stochastic Oscillator
  • NEPH 19.35
  • HHS 24.19

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

Share on Social Networks: